Drug Information
Drug General Information | |||||
---|---|---|---|---|---|
Drug ID |
D0V1CL
|
||||
Former ID |
DNC004226
|
||||
Drug Name |
Cartazolate
|
||||
Drug Type |
Small molecular drug
|
||||
Indication | Discovery agent | Investigative | [526024] | ||
Structure |
Download2D MOL |
||||
Formula |
C15H22N4O2
|
||||
Canonical SMILES |
CCCCNC1=C2C=NN(C2=NC=C1C(=O)OCC)CC
|
||||
InChI |
1S/C15H22N4O2/c1-4-7-8-16-13-11-10-18-19(5-2)14(11)17-9-12(13)15(20)21-6-3/h9-10H,4-8H2,1-3H3,(H,16,17)
|
||||
InChIKey |
IQNQAOGGWGCROX-UHFFFAOYSA-N
|
||||
CAS Number |
CAS 34966-41-1
|
||||
PubChem Compound ID | |||||
Target and Pathway | |||||
Target(s) | CGMP-specific 3',5'-cyclic phosphodiesterase | Target Info | Inhibitor | [526024] | |
KEGG Pathway | Purine metabolism | ||||
cGMP-PKG signaling pathway | |||||
NetPath Pathway | TGF_beta_Receptor Signaling Pathway | ||||
Reactome | cGMP effects | ||||
References |
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.